Translational Cancer Research

Papers
(The H4-Index of Translational Cancer Research is 15. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Functions of polyphenols and its anticancer properties in biomedical research: a narrative review63
MicroRNAs: potential biomarkers for diagnosis and prognosis of different cancers30
Sarcopenia in aging, obesity, and cancer28
A review of research progress of antitumor drugs based on tubulin targets24
Claudin 18.2 expression in various tumor types and its role as a potential target in advanced gastric cancer23
Mismatch repair testing in breast cancer: the path to tumor-specific immuno-oncology biomarkers22
p16 a biomarker of aging and tolerance for cancer therapy21
Curcumin reverses the sunitinib resistance in clear cell renal cell carcinoma (ccRCC) through the induction of ferroptosis via the ADAMTS18 gene21
Strategies for enrichment of circulating tumor cells20
Sarcopenia and visceral adiposity predict poor overall survival in hepatocellular carcinoma patients after curative hepatic resection18
Variant histology in bladder cancer: diagnostic and clinical implications18
Impact of oral mucositis on quality of life in patients undergoing oncological treatment: a systematic review16
Current role of Pipelle endometrial sampling in early diagnosis of endometrial cancer16
Patient-derived tumor spheroid cultures as a promising tool to assist personalized therapeutic decisions in breast cancer15
A prognostic model guides surgical resection in cervical squamous cell carcinoma15
MicroRNAs in head and neck squamous cell carcinoma: a possible challenge as biomarkers, determinants for the choice of therapy and targets for personalized molecular therapies15
0.056121110916138